Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

por Loskog, Angelica
Publicado 2015

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses

por Labani-Motlagh, Alireza, Ashja-Mahdavi, Mehrnoush, Loskog, Angelica
Publicado 2020

Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer

por Eriksson, Emma, Wenthe, Jessica, Irenaeus, Sandra, Loskog, Angelica, Ullenhag, Gustav
Publicado 2016

Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

por Labani-Motlagh, Alireza, Naseri, Sedigheh, Wenthe, Jessica, Eriksson, Emma, Loskog, Angelica
Publicado 2021

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

por Hellström, Vivan, Tufveson, Gunnar, Loskog, Angelica, Bengtsson, Mats, Enblad, Gunilla, Lorant, Tomas
Publicado 2022

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40

por Wenthe, Jessica, Naseri, Sedigheh, Hellström, Ann-Charlotte, Wiklund, Helena Jernberg, Eriksson, Emma, Loskog, Angelica
Publicado 2020

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

por Sandin, Linda C, Eriksson, Fredrik, Ellmark, Peter, Loskog, Angelica SI, Tötterman, Thomas H, Mangsbo, Sara M
Publicado 2014

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

por Wenthe, Jessica, Eriksson, Emma, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Loskog, Angelica
Publicado 2023

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

por Karlsson, Hannah, Svensson, Emma, Gigg, Camilla, Jarvius, Malin, Olsson-Strömberg, Ulla, Savoldo, Barbara, Dotti, Gianpietro, Loskog, Angelica
Publicado 2015

Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia

por Christiansson, Lisa, Söderlund, Stina, Svensson, Emma, Mustjoki, Satu, Bengtsson, Mats, Simonsson, Bengt, Olsson-Strömberg, Ulla, Loskog, Angelica S. I.
Publicado 2013

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

por Schiza, Aglaia, Irenaeus, Sandra, Ortiz-Nieto, Francisco, Loskog, Angelica, Tötterman, Thomas, Sundin, Anders, Ullenhag, Gustav J., Ahlström, Håkan
Publicado 2019

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

por Wenthe, Jessica, Naseri, Sedigheh, Labani-Motlagh, Alireza, Enblad, Gunilla, Wikström, Kristina I., Eriksson, Emma, Loskog, Angelica, Lövgren, Tanja
Publicado 2021

Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition

por Wenthe, Jessica, Naseri, Sedigheh, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Eriksson, Emma, Loskog, Angelica
Publicado 2022

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

por Sjöholm, Therese, Korenyushkin, Alexander, Gammelgård, Gustav, Sarén, Tina, Lövgren, Tanja, Loskog, Angelica, Essand, Magnus, Kullberg, Joel, Enblad, Gunilla, Ahlström, Håkan
Publicado 2023

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing

por Rubin, Jenny, Mansoori, Sharmineh, Blom, Kristin, Berglund, Malin, Lenhammar, Lena, Andersson, Claes, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf
Publicado 2018

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

por Sjöholm, Therese, Korenyushkin, Alexander, Gammelgård, Gustav, Sarén, Tina, Lövgren, Tanja, Loskog, Angelica, Essand, Magnus, Kullberg, Joel, Enblad, Gunilla, Ahlström, Håkan
Publicado 2022

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition

por Blom, Kristin, Rubin, Jenny, Berglund, Malin, Jarvius, Malin, Lenhammar, Lena, Parrow, Vendela, Andersson, Claes, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf
Publicado 2019

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up

por Saellstrom, Sara, Sadeghi, Arian, Eriksson, Emma, Segall, Thomas, Dimopoulou, Maria, Korsgren, Olle, Loskog, Angelica SI., Tötterman, Thomas H., Hemminki, Akseli, Ronnberg, Henrik
Publicado 2021

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

por Fransson, Moa, Piras, Elena, Burman, Joachim, Nilsson, Berith, Essand, Magnus, Lu, BinFeng, Harris, Robert A, Magnusson, Peetra U, Brittebo, Eva, Loskog, Angelica SI
Publicado 2012

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

por Loskog, Angelica, Maleka, Aglaia, Mangsbo, Sara, Svensson, Emma, Lundberg, Christina, Nilsson, Anders, Krause, Johan, Agnarsdóttir, Margrét, Sundin, Anders, Ahlström, Håkan, Tötterman, Thomas H, Ullenhag, Gustav
Publicado 2016